20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses
暂无分享,去创建一个
M. Parmar | M. Sydes | S. Burdett | B. Tombal | N. James | N. Clarke | M. Mason | C. Sweeney | K. Fizazi | J. Tierney | L. Rydzewska | L. Albiges | C. Vale | D. Fisher